Affibody Ab Is A Clinical Stage Biotechnology Company Based In Swedendedicated To Developing Next Generation Biopharmaceuticalsthe Company Leverages Its Proprietary Technology Platformsincluding Affibodyamolecules And Albumoda Cto Create Innovative Biotherapeuticsaffibody Operates With A Focused Experimental Medicines Modelaiming To Evolve Into An Integrated Biopharma Company The Company Has Several Clinical Stage Therapeutic Programs Targeting Conditions Such As Psoriasisb Cell Driven Autoimmune Diseasesand Liver Diseasesadditionallyaffibody Is Advancing A Diagnostic Imaging Program Aimed At Metastatic Breast Cancerit Maintains Commercial Relationships With Notable Partnersincluding Abclonalexionand Ge Healthcarefounded In 1998 By Researchers From The Royal Institute Of Technology And The Karolinska Instituteaffibody Is Committed To Good Corporate Governance And Transparency
